LVMH financials
This article was originally published in The Rose Sheet
Executive Summary
Perfumes & Cosmetics division sales gain 7.3% to $550.2 mil. (€1=$.98) in third quarter due to successful launch of Christian Dior women's scent Dior Addict and roll out of Givenchy Pour Homme and Eau Torride fragrances, luxury goods manufacturer says. Double-digit sales growth at BeneFit Cosmetics and Fresh also helped to fuel sales, firm adds in its 1third quarter sales and earnings release Oct. 15. Sales in the Selective Retailing division, which includes Sephora and duty-free sales, fell 7.4% to $782.8 mil., due to slow recovery in travel retail, LVMH notes. In the U.S., Sephora recorded a 32% sales gain for the nine months, and Perfumes & Cosmetics division sales increased 6% in the region. Consolidated sales increased 2.2% to $8.68 bil. for first nine months of the year...
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.